United States

Analyst Research Report Snapshot


Net Medical Xpress Solutions, Inc. (NMXS) - Financial Analysis Review






03 May 2013





Companies referenced:


Available for Immediate Download

Net Medical Xpress Solutions, Inc. (NMXS) - Financial Analysis Review Summary Net Medical Xpress Solutions, Inc. (NMX), formerly New Mexico Software, Inc., is a healthcare IT company. It provides Picture Archiving and Communication System (PACs) hardware and software to hospitals and other medical facilities. The company’s major products include XR-EXpress system, XR-EXpress Workstation, XR-EXpress for Mobile Devices and Xpress Safety Pilot. Its solutions are used for the management of digital documents, video clips, high-resolution graphic images and audio recordings. GlobalData's Net Medical Xpress Solutions, Inc. (NMXS) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years. Net Medical Xpress Solutions, Inc. Key Recent Developments: Apr 15, 2013: Net Medical To Exhibit Telemedicine Technology At American Telemedicine Association Tradeshow In Austin Jan 10, 2013: Net Medical Xpress Solutions Announces Change Of Ticker Symbol To NMXS Dec 27, 2012: New Mexico Software Officially Changes Name To Net Medical Xpress Solutions Feb 28, 2012: New Mexico Software Prevails In Lawsuit This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope - Business description - A detailed description of the company's operations and business divisions. - Company history - Progression of key events associated with the company. - Major products and services - A list of major products, services and brands of the company. - Key competitors - A list of key competitors to the company. - Key employees - A list of the key executives of the company. - Executive biographies - A brief summary of the executives' employment history. - Key operational heads - A list of personnel heading key departments/functions. - Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details. - Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Note: Some sections may be missing if data is unavailable for the company. Reasons to Buy - Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. - Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services. - Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.